The Global Biotinidase Deficiency Market is being strongly driven by a combination of clinical, technological, and healthcare system advancements that are improving diagnosis, treatment, and overall disease management. As awareness of rare metabolic disorders continues to grow, several key factors are accelerating the expansion of this market. One of the primary drivers is the increasing adoption of newborn screening programs across the globe. Early detection of biotinidase deficiency is critical, as timely treatment can prevent severe neurological and developmental complications. Governments and healthcare organizations are increasingly incorporating this condition into mandatory neonatal screening panels, significantly boosting demand for diagnostic tests and related services. Read More - https://www.theinsightpartners.com/reports/biotinidase-deficiency-market